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The present study was aimed at gaining insight into the
function of p13, an 87-amino acid mitochondrial protein
expressed by HTLV-1. Although necessary for viral pro-
pagation in vivo, the mechanism of p13 function is
incompletely understood. In previous studies we showed
that p13 exerts antitumor effects in experimental trans-
formation models. More recently, using synthetic p13
and isolated mitochondria, we showed that the protein
triggers an inward K+ current that leads to mitochon-
drial depolarization, increased activity of the respiratory
chain, and reactive oxygen species (ROS) production.
These findings prompted us to test the effects of p13 on
ROS in living cells, including T-cells, the main targets of
HTLV-1 infection in vivo.
Expression of p13 in primary T-cells resulted in cell
activation, measured using the CD38 surface marker.
p13-induced activation was blocked in the presence of
ROS scavengers and was not observed using a p13
mutant that was inactive in the in vitro assays, indicat-
ing a connection between the effects on ROS those on
mitochondrial K+ influx. In the context of the trans-
formed cell line Jurkat, p13 did not affect ROS levels
unless the cells were subjected to glucose deprivation,
which led to a p13-dependent increase in ROS and cell
death. Using RNA interference we confirmed that
expression of p13 also influences glucose starvation-
induced cell death in HTLV-1-infected cells. Taken
together, our findings indicate that in the context of the
HTLV-1 propagation strategy, p13 could increase the
pool of “normal” infected cells while culling cells acquir-
ing a transformed phenotype, thus favoring life-long
persistence of the virus in the host.
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